{
"id":"mk19_a_id_q014",
"number":14,
"bookId":"id",
"correctAnswer":"C",
"title":"Question 14",
"stimulus":[
{
"type":"p",
"hlId":"91054a",
"class":"updated",
"children":[
"This question has been updated as a result of postpublication analysis and/or new data that are relevant to the question."
]
},
{
"type":"p",
"hlId":"ac964d",
"children":[
"A 23-year-old woman undergoes follow-up after treatment for gonococcal arthritis; she was treated with ceftriaxone. Medical history is notable for meningococcal meningitis as a child. The patient takes no medications."
]
},
{
"type":"p",
"hlId":"b246a5",
"children":[
"On physical examination, she feels well with complete resolution of symptoms. Vital signs are normal, and the examination is unremarkable."
]
}
],
"prompt":[
" ",
{
"type":"p",
"hlId":"9978a9",
"children":[
"Which of the following is the most appropriate screening test to perform next?"
]
},
" "
],
"options":[
{
"letter":"A",
"text":{
"__html":"CD4 lymphocyte subset"
}
},
{
"letter":"B",
"text":{
"__html":"Serum IgA level"
}
},
{
"letter":"C",
"text":{
"__html":"Total hemolytic complement (CH<sub>50</sub>) level"
}
},
{
"letter":"D",
"text":{
"__html":"No additional testing"
}
}
],
"keypoints":[
{
"type":"keypoint",
"hlId":"18c1d1",
"children":[
"A personal history of recurrent ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Neisseria"
]
},
" infection or a history of ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Neisseria"
]
},
" infections among multiple family members is an indication to screen for terminal complement deficiency by measuring total hemolytic complement (CH",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"50"
]
},
") level."
]
},
{
"type":"keypoint",
"hlId":"14a718",
"children":[
"Patients with terminal complement deficiency should receive the conjugate and serogroup B meningococcal vaccines."
]
}
],
"exposition":[
{
"type":"p",
"hlId":"940411",
"children":[
"This patient should be evaluated for a defect in terminal complement level by testing the total hemolytic complement (CH",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"50"
]
},
") level (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option C"
]
},
"). She has a personal history of disseminated gonorrhea and meningococcemia. The terminal complement pathway includes C5 to C9, which together form the membrane attack complex, or MAC. The MAC plays a key role in host immunity against ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Neisseria"
]
},
" species, and deficiency of a late complement component is associated with an up to 10,000-fold increased risk of meningococcal disease. Counterintuitively, although patients with terminal complement deficiencies are at increased risk of disseminated ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Neisseria"
]
},
" infection, including meningococcal meningitis, these tend to be relatively mild and are rarely life-threatening. A personal history of recurrent ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Neisseria"
]
},
" infection or a history of ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Neisseria"
]
},
" infections among multiple family members is an indication to test for terminal complement deficiency. Some studies suggest up to a 20% prevalence of complement deficiency among patients with invasive meningococcal disease, justifying screening at the time of initial presentation, regardless of family history. In patients with a low CH",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"50"
]
},
" level, more specialized testing can be performed to identify the specific protein deficiency. Patients with deficiencies in terminal complement levels should receive the conjugate and serogroup B meningococcal vaccines."
]
},
{
"type":"p",
"hlId":"56df44",
"children":[
"Idiopathic CD4 lymphopenia is associated with decreased T-cell function, and these patients are at risk for the same opportunistic infections seen in patients with HIV or AIDS, depending on the absolute level, but not ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Neisseria"
]
},
" infections (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option A"
]
},
")."
]
},
{
"type":"p",
"hlId":"3263b7",
"children":[
"Selective IgA deficiency is the most common cause of primary immunodeficiency but is frequently asymptomatic (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option B"
]
},
"). Recurrent sinus or pulmonary infections are the most common infectious complications of selective IgA deficiency, not ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Neisseria"
]
},
" infections."
]
},
{
"type":"p",
"hlId":"e1dc49",
"children":[
"Not testing further would be inappropriate for this patient with a personal history of ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Neisseria"
]
},
" infection (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option D"
]
},
"). The identification of late complement deficiency has therapeutic implications because these patients should receive the conjugate and serogroup B meningococcal vaccines."
]
}
],
"relatedSection":"mk19_a_id_s12_2_3",
"objective":{
"__html":"Evaluate a patient for deficiency in terminal complement levels."
},
"references":[
[
"Devonshire AL, Makhija M. Approach to primary immunodeficiency. Allergy Asthma Proc. 2019;40:465-469. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/31690396",
"target":"_blank"
},
"children":[
"PMID: 31690396"
]
},
" doi:10.2500/aap.2019.40.4273"
]
],
"hospitalist":false,
"hvc":false,
"peerComparison":{
"A":4,
"B":6,
"C":58,
"D":33,
"E":0
},
"hlIds":[
"91054a",
"ac964d",
"b246a5",
"9978a9",
"18c1d1",
"14a718",
"940411",
"56df44",
"3263b7",
"e1dc49"
]
}